ATE545424T1 - Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax - Google Patents

Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax

Info

Publication number
ATE545424T1
ATE545424T1 AT08788551T AT08788551T ATE545424T1 AT E545424 T1 ATE545424 T1 AT E545424T1 AT 08788551 T AT08788551 T AT 08788551T AT 08788551 T AT08788551 T AT 08788551T AT E545424 T1 ATE545424 T1 AT E545424T1
Authority
AT
Austria
Prior art keywords
pneumothorax
pleural effusion
treatment
compositions containing
relates
Prior art date
Application number
AT08788551T
Other languages
German (de)
English (en)
Inventor
Robert Davies
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE545424T1 publication Critical patent/ATE545424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08788551T 2007-09-07 2008-09-08 Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax ATE545424T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0717442.8A GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof
PCT/GB2008/003019 WO2009030929A1 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax

Publications (1)

Publication Number Publication Date
ATE545424T1 true ATE545424T1 (de) 2012-03-15

Family

ID=38640413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08788551T ATE545424T1 (de) 2007-09-07 2008-09-08 Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax

Country Status (8)

Country Link
US (1) US8536139B2 (enExample)
EP (1) EP2194991B1 (enExample)
JP (1) JP5623906B2 (enExample)
CN (1) CN101801392B (enExample)
AT (1) ATE545424T1 (enExample)
ES (1) ES2382501T3 (enExample)
GB (1) GB0717442D0 (enExample)
WO (1) WO2009030929A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8611854U1 (de) 1986-04-30 1986-06-19 Stahl Gmbh & Co Maschinenfabrik, 7140 Ludwigsburg Kombinierte Vierbruchfalzmaschine
EP2545909A1 (en) * 2011-07-12 2013-01-16 Lunamed AG Combination of D-Amino Acids and Lipoteichoic Acid
EP2589387A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
EP2589388A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a Teichoic acid for the treatment of malignant ascites
CN103961512A (zh) * 2014-06-02 2014-08-06 王志红 一种用于创伤性气胸护理的中药制剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4714196A (en) * 1995-01-30 1996-08-21 Peter Truog Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
WO2005030133A2 (en) 2003-09-22 2005-04-07 Yale University Treatment with agonists of toll-like receptors
WO2008048560A2 (en) 2006-10-16 2008-04-24 Yale University Toll-like receptor agonist regulation of vegf-induced tissue responses

Also Published As

Publication number Publication date
JP2010538054A (ja) 2010-12-09
ES2382501T3 (es) 2012-06-08
EP2194991A1 (en) 2010-06-16
JP5623906B2 (ja) 2014-11-12
WO2009030929A1 (en) 2009-03-12
US8536139B2 (en) 2013-09-17
GB0717442D0 (en) 2007-10-17
EP2194991B1 (en) 2012-02-15
CN101801392B (zh) 2012-09-05
US20110059908A1 (en) 2011-03-10
CN101801392A (zh) 2010-08-11

Similar Documents

Publication Publication Date Title
MD20130095A2 (ro) Compuşi condensaţi de benzoxazepinone ca modulatori ai canalelor ionice
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EA201590457A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
ATE395905T1 (de) Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
EA200870380A1 (ru) Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета
EA201691590A1 (ru) Бензимидазол-2-амины в качестве ингибиторов midhi
EA201591180A1 (ru) Составы ингибитора lfa-1
PH12019501469A1 (en) Compositions and methods for treating biofilms
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
ATE462438T1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
MX388251B (es) Nuevo anticuerpo que se una a tfpi y composicion que comprende el mismo.
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
ATE545424T1 (de) Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax
EA201600398A1 (ru) Тиенопиримидины в качестве ингибиторов mknk1 и mknk2
EA202091446A1 (ru) Способы лечения хронических воспалительных заболеваний
EA201792341A1 (ru) Производные пиразола, пригодные в качестве ингибиторов белка, активирующего 5-липоксигеназу (flap)
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
EP3909576A4 (en) USE OF CHLOROGENIC ACID IN THE PREPARATION OF A MEDICINE OR A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF PAIN
ATE489380T1 (de) Hydratformen von amg706
EA033769B9 (ru) Отселектированный амид -гидроксимасляной кислоты и его применения при лечении злоупотребления алкоголем
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
SG10201900006XA (en) Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same
MX2013011561A (es) Compuestos de benzodioxepina y benzodioxina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
BR112015028884A2 (pt) tratamento ou prevenção de depressão utilizando mentol e/ou icilina